Hancock Mark 4

What Happened Mark Hancock, reported as a 10% owner of PACS Group, sold a total of 161,068 shares in three open-market transactions between July 1–6, 2026, generating approximately $7,295,866 in proceeds. The sales were: 6,080 shares at a weighted average $45.02 ($273,716), 12,825 shares at $45.01 ($577,290), and 142,163 shares at $45.33 ($6,444,860). On July 1, 2026 Hancock was also granted 4,287 restricted stock units (RSUs) that will convert to common shares upon vesting.

Key Details

• Transaction dates and weighted-average prices:
  • 2026-07-01: Sale 6,080 shares @ $45.02 (WAP) — $273,716
  • 2026-07-02: Sale 12,825 shares @ $45.01 (WAP) — $577,290
  • 2026-07-06: Sale 142,163 shares @ $45.33 (WAP) — $6,444,860
  • 2026-07-01: Award of 4,287 RSUs @ $0.00 (grant)
• Total proceeds from sales: $7,295,866 (approx. $7.30M).
• Filing date: Form 4 filed July 6, 2026 reporting transactions from July 1–6, 2026. The filing does not flag a late-reporting notice.
• Shares owned after the transactions: not specified in the information provided in this summary.
• Footnotes of note:
  • F1: The 4,287 RSUs convert 1:1 to shares and vest 100% on the earlier of July 1, 2027 or the next annual meeting, subject to continued service.
  • F2: At least one sale was executed under a Rule 10b5-1 trading plan adopted March 11, 2026 (indicates a prearranged trading program).
  • F3–F5: Reported prices are weighted averages; individual trades ranged roughly $45.00 to $45.88 per share across the transactions.

Context

• These transactions are sales by a 10% owner and include shares sold under a 10b5-1 plan, which is a pre-set trading arrangement; that typically means the sales were scheduled in advance rather than based on immediate market views. RSU grants are awards that vest in the future and do not by themselves signal buying interest. For retail investors, purchases typically carry more weight as a bullish signal; here the activity is primarily disposals with an accompanying time‑based equity award.